Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Wnt signalling system controls many fundamental processes during animal development and its deregulation has been causally linked to colorectal cancer. Transduction of Wnt signals entails the association of
beta-catenin
with nuclear TCF DNA-binding factors and the subsequent activation of target genes. Using genetic assays in Drosophila, we have recently identified a presumptive adaptor protein, Legless (Lgs), that binds to
beta-catenin
and mediates signalling activity by recruiting the
transcriptional activator
Pygopus (Pygo). Here, we characterize the
beta-catenin
/Lgs interaction and show: (1) that it is critically dependent on two acidic amino acid residues in the first Armadillo repeat of
beta-catenin
; (2) that it is spatially and functionally separable from the binding sites for TCF factors, APC and E-cadherin; (3) that it is required in endogenous as well as constitutively active forms of
beta-catenin
for Wingless signalling output in Drosophila; and (4) that in its absence animals develop with the same phenotypic consequences as animals lacking Lgs altogether. Based on these findings, and because Lgs and Pygo have human homologues that can substitute for their Drosophila counterparts, we infer that the
beta-catenin
/Lgs binding site may thus serve as an attractive drug target for therapeutic intervention in
beta-catenin
-dependent cancer progression.
...
PMID:Identification and in vivo role of the Armadillo-Legless interaction. 1529 66
Frodo is a novel conserved regulator of Wnt signaling that has been identified by its association with Dishevelled, an intracellular component of Wnt signal transduction. To understand further how Frodo functions, we have analyzed its role in neural development using specific morpholino antisense oligonucleotides. We show that Frodo and the closely related Dapper synergistically regulate head development and morphogenesis. Both genes were cell-autonomously required for neural tissue formation, as defined by the pan-neural markers sox2 and nrp1. By contrast,
beta-catenin
was not required for pan-neural marker expression, but was involved in the control of the anteroposterior patterning. In the mesoderm, Frodo and Dapper were essential for the expression of the organizer genes chordin, cerberus and Xnr3, but they were not necessary for the expression of siamois and goosecoid, established targets of
beta-catenin
signaling. Embryos depleted of either gene showed a decreased transcriptional response to TCF3-VP16, a
beta-catenin
-independent
transcriptional activator
. Whereas the C terminus of Frodo binds Dishevelled, we demonstrate that the conserved N-terminal domain associates with TCF3. Based on these observations, we propose that Frodo and Dapper link Dsh and TCF to regulate Wnt target genes in a pathway parallel to that of
beta-catenin
.
...
PMID:The involvement of Frodo in TCF-dependent signaling and neural tissue development. 1532 48
Peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear receptor regulating an array of diverse functions in a variety of cell types including regulation of genes associated with growth and differentiation. Its most notable function is to regulate development of adipose tissue, which involves coordinating expression of many hundreds of genes responsible for establishment of the mature adipocyte phenotype. Our recent studies have demonstrated a role for MEK/ERK signaling and CCAAT/enhancer binding proteins (C/EBP)beta in regulating expression of PPARgamma during adipogenesis. Furthermore, we have shown that cAMP-dependent signaling along with C/EBPbeta leads to the stimulation of PPARgamma activity by mechanisms that probably involve production of PPARgamma ligands. Additionally, we have recently demonstrated that phosphorylation of C/EBPbeta at a consensus ERK/GSK3 site is required for the PPARgamma-associated expression of adiponectin during the terminal stages of adipogenesis. GSK3beta also influences PPARgamma activity by regulating the turnover and subcellular localization of
beta-catenin
, a potent
transcriptional activator
of Wnt signaling. In fact, we have recently shown a crosstalk between PPARgamma and
beta-catenin
signaling. Specifically, activation of PPARgamma induces the degradation of
beta-catenin
during preadipocyte differentiation by mechanisms that require GSK3beta and the proteasome. In contrast, expression of a GSK3beta-phosphorylation-defective
beta-catenin
renders
beta-catenin
resistant to the degradatory action of PPARgamma. Interestingly, expression of the mutant
beta-catenin
blocks expression of adiponectin and C/EBPalpha in response to the activation of PPARgamma.
...
PMID:Regulation of PPARgamma activity during adipogenesis. 1571 76
Tcf/Lef transcription factors play an important role in mediating canonical Wnt signaling. When bound by
beta-catenin
, Tcf/Lef proteins either activate or de-repress gene transcription. In zebrafish, four members have been identified: Lef1, Tcf3, Tcf3b, and Tcf4. Here, we report the cloning and expression of the tcf7 gene. Forms of Tcf7 expressed in the embryo contain two highly conserved regions: an N-terminal
beta-catenin
binding domain and a C-terminal HMG domain. Tcf7 lacks a putative Groucho corepressor binding site, suggesting that, like Lef1, it functions as a
transcriptional activator
. We isolated three C-terminal splice variants of tcf7 corresponding to human B, C, and D isoforms. tcf7 expression overlaps with lef1 expression maternally, in the tail bud, fin buds, and paraxial mesoderm, and we expect that the two genes function redundantly in those areas. tcf7 is also expressed in nonoverlapping areas such as the prechordal mesoderm, dorsal retina, and median fin fold, suggesting unique functions.
...
PMID:Expression pattern of zebrafish tcf7 suggests unexplored domains of Wnt/beta-catenin activity. 1576 2
The DNA binding architectural protein, TCF, and the
transcriptional activator
,
beta-catenin
, form a complex that regulates the expression of diverse target genes during early development and carcinogenesis. As an approach to modulating transcription by this complex, we selected an RNA aptamer that binds to the DNA binding domain of TCF-1. The aptamer interfered with the binding of TCF-1 to its specific DNA recognition sequences in vitro and also inhibited DNA binding of cellular TCF-1. We also developed the truncated version of the aptamer for efficient delivery to the cells. Structural analysis of the truncated aptamer revealed that a stem-loop with an internal loop was responsible for the binding to TCF-1. Similar approach may well be applicable to other proteins, especially DNA binding transcription factors, in order to modulate their DNA binding and transcriptional activity in the cells.
...
PMID:Inhibition of the DNA binding by the TCF-1 binding RNA aptamer. 1578 Dec 25
Beta-catenin
is a
transcriptional activator
shown to regulate the embryonic, postnatal, and oncogenic growth of many tissues. In most research to date,
beta-catenin
activation has been the unique downstream function of the Wnt signaling pathway. However, in the heart, a Wnt-independent mechanism involving Akt-mediated phosphorylation of glycogen synthase kinase (GSK)-3beta was recently shown to activate
beta-catenin
and regulate cardiomyocyte growth. In this study, results have identified the activation of the Wnt/
beta-catenin
pathway during hypertrophy of mechanically overloaded skeletal muscle. Significant increases in
beta-catenin
were determined during skeletal muscle hypertrophy. In addition, the Wnt receptor, mFrizzled (mFzd)-1, the signaling mediator disheveled-1, and the transcriptional co-activator, lymphocyte enhancement factor (Lef)-1, are all increased during hypertrophy of the overloaded mouse plantaris muscle. Experiments also determined an increased association between GSK-3beta and the inhibitory frequently rearranged in advanced T cell-1 protein with no increase in GSK-3beta phosphorylation (Ser9). Finally, skeletal muscle overload resulted in increased nuclear
beta-catenin
/Lef-1 expression and induction of the transcriptional targets c-Myc, cyclin D1, and paired-like homeodomain transcription factor 2. Thus this study provides the first evidence that the Wnt signaling pathway induces
beta-catenin
/Lef-1 activation of growth-control genes during overload induced skeletal muscle hypertrophy.
...
PMID:Wnt/beta-catenin signaling activates growth-control genes during overload-induced skeletal muscle hypertrophy. 1588 52
Invasion by colorectal carcinomas is characterized by an epithelial-mesenchymal transition (EMT)-like dedifferentiation of the tumor cells. However, a redifferentiation towards an epithelial phenotype, resembling a mesenchymal-epithelial transition, is detectable in metastases. This indicates that malignant progression is based on dynamic processes, which cannot be explained solely by irreversible genetic alterations, but must be additionally regulated by the tumor environment. The main oncoprotein in colorectal cancer is the Wnt pathway effector
beta-catenin
, which is overexpressed due to mutations in the APC tumor suppressor in most cases. EMT of the tumor cells is associated with a nuclear accumulation of the
transcriptional activator
beta-catenin
, which is reversed in metastases. Nuclear
beta-catenin
is involved in two fundamental processes in embryonic development: EMT and stem cell formation. Accumulating data demonstrate that aberrant nuclear expression of
beta-catenin
can also confer these two abilities to tumor cells, thereby driving malignant tumor progression.
...
PMID:Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. 1594 93
Siah-interacting protein (SIP) was identified as a novel adaptor that physically links the E3 ubiquitin ligase activity of Siah-1 with Skp1 and Ebi F-Box protein in the degradation of
beta-catenin
, a
transcriptional activator
of TCF/LEF genes. In this study, we have used solution NMR spectroscopy to characterize the domain structure of SIP, which includes a novel helical hairpin domain at the N-terminus flexibly linked to a CS domain and an unstructured carboxy terminal SGS domain. These studies have been complemented by mapping the sites of functionally important protein-protein interactions involving Siah-1 and Skp1 to individual domains of SIP. NMR-based chemical shift perturbation assays show that Siah-1 interacts with the flexible linker between SIP N and CS domains. This site for interaction in the linker does not perturb residues in the structured region at the N-terminus but does appear to restrict the rotational freedom of the SIP CS domain in the context of the full-length protein. In contrast, Skp1 engages the SIP CS domain exclusively through weak interactions that are not coupled to the other domains. The principal role of the modular structure of SIP appears to be in bringing these two proteins into physical proximity and orchestrating the orientation required for polyubiquitination of
beta-catenin
in the intact SCF-type complex.
...
PMID:The modular structure of SIP facilitates its role in stabilizing multiprotein assemblies. 1599 1
beta-Catenin is a cadherin-binding protein involved in cell-cell adhesion, which also functions as a
transcriptional activator
when complexed in the nucleus with members of the T-cell factor (TCF)/lymphoid enhancer factor (LEF) family of proteins. There is considerable interest in mechanisms that down-regulate
beta-catenin
, since this provides an avenue for the prevention of colorectal and other cancers in which
beta-catenin
is frequently over-expressed. We show here that physiologically relevant concentrations of the tea polyphenol epigallocatechin-3-gallate (EGCG) inhibited
beta-catenin
/TCF-dependent reporter activity in human embryonic kidney 293 cells transfected with wild type or mutant beta-catenins, and there was a corresponding decrease in
beta-catenin
protein levels in the nuclear, cytosolic and membrane-associated fractions. However,
beta-catenin
accumulated as punctate aggregates in response to EGCG treatment, including in human colon cancer cells over-expressing
beta-catenin
endogenously. Confocal microscopy studies revealed that the aggregated
beta-catenin
in HEK293 cells was extra-nuclear and co-localized with lysosomes, suggesting that EGCG activated a pathway involving lysosomal trafficking of
beta-catenin
. Lysosomal inhibitors leupeptin and transepoxysuccinyl-l-leucylamido(4-guanido)butane produced an increase in
beta-catenin
protein in total cell lysates, without a concomitant increase in
beta-catenin
transcriptional activity. These data provide the first evidence that EGCG facilitates the trafficking of
beta-catenin
into lysosomes, presumably as a mechanism for sequestering
beta-catenin
and circumventing further nuclear transport and activation of
beta-catenin
/TCF/LEF signaling.
...
PMID:Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3-gallate. 1605 65
Early in vertebrate development, endodermal signals act on mesoderm to induce cardiogenesis. The F-type SOXs SOX7 and SOX18beta are expressed in the cardiogenic region of the early Xenopus embryo. Injection of RNAs encoding SOX7 or SOX18beta, but not the related F-type SOX, SOX17, leads to the nodal-dependent expression of markers of cardiogenesis in animal cap explants. Injection of morpholinos directed against either SOX7 or SOX18mRNAs lead to a partial inhibition of cardiogenesis in vivo, while co-injection of SOX7 and SOX18 morpholinos strongly inhibited cardiogenesis. SOX7 RNA rescued the effects of the SOX18 morpholino and visa versa, indicating that the proteins have redundant functions. In animal cap explants, it appears that SOX7 and SOX18 act indirectly through Xnr2 to induce mesodermal (Eomesodermin, Snail, Wnt11), organizer (Cerberus) and endodermal (endodermin, Hex) tissues, which then interact to initiate cardiogenesis. Versions of SOX7 and SOX18 with their C-terminal,
beta-catenin
interaction domains replaced by a
transcriptional activator
domain failed to antagonize
beta-catenin
activation of Siamois, but still induced cardiogenesis. These observations identify SOX7 and SOX18 as important, and previously unsuspected, regulators of cardiogenesis in Xenopus.
...
PMID:SOX7 and SOX18 are essential for cardiogenesis in Xenopus. 1619 13
<< Previous
1
2
3
4
5
6
7
8
Next >>